Enzon Pharmaceuticals Inc Watch

from 10-Q 13 pages Indemnification Agreement

from 10-K 1 page First Amendment to the Second Amended and Restated By-Laws of Enzon Pharmaceuticals, Inc

from 8-K 19 pages Investment Agreement by and Between Enzon Pharmaceuticals, Inc. and Icahn Capital LP Dated as of September 1, 2020

from S-1 19 pages Investment Agreement by and Between Enzon Pharmaceuticals, Inc. and Icahn Capital LP Dated as of September 1, 2020

from 10-K 4 pages Reference Is Made to That Certain Asset Purchase Agreement, Dated as of November 9, 2009, by and Between Klee Pharmaceuticals, Inc. (“Klee”), Defiante Farmaceutica, S.A. (“Defiante”), and Sigma-Tan Finanziaria S.P.A. (Solely for the Purpose of Section 6.4, Section 7.8(a), Section 7.8(e) and Section 12.17 Thereof), on the One Hand, and Enzon Pharmaceuticals, Inc. (“Enzon”), on the Other Hand (The “Apa”). Capitalized Terms Used in This Letter Agreement Without Definition Shall Have the Meanings Given to Them in the Apa

from 10-K 22 pages Amended and Restated Exclusive Ip Marketing Agreement

from 10-K/A 1 page Third Amendment to Separation Agreement

from 10-K/A 2 pages Amendment 2 Independent Contractor Agreement

from 10-Q 3 pages Amendment 2 to Separation Agreement

from 10-Q 1 page Amendment to Separation Agreement

from 10-K 3 pages Re: Transactions Related to the Termination of That Certain Indenture of Lease Dated April 1, 1995 Between Enzon and Landlord’s Predecessor (The “Prime Lease”) and Enzon’s Leasing of the Premises Demised Thereby (The “Premises”), the Transfer of the Sublandlord’s Interest in and to That Certain Amended and Restated Agreement of Sublease Dated as of November 13, 2013 (The “Agreement”) by and Between Enzon Pharmaceuticals. Inc., as Sublandlord (“Enzon”) and Axcellerate Pharma, LLC, as Subtenant (“Axcellerate”), Together With That Certain Consent to Sublease and Amendment to Lease Dated as of November 14, 2013 (The “Consent”) by and Among Enzon, Axcellerate and Kingsbridge 2005, LLC, as Prime Landlord (“Kingsbridge”) (Such Agreement, Together With Such Consent, Collectively, the “Sublease”), and Those Matters Set Forth in That Certain Surrender and Release Agreement Dated as of December 29, 2015 (The “Tri-Party Agreement”) by and Among Enzon, Axcellerate and Kingsbridge Dear Sir or Madam

from 10-K 4 pages Agreement

from 10-K 2 pages Amendment 1 Independent Contractor Agreement

from 10-Q 8 pages Assignment, Assumption and Release Agreement

from 10-K 4 pages Independent Contractor Agreement

from 10-K 6 pages Separation Agreement

from 10-K 38 pages -I- -II- Amended and Restated Agreement of Sublease

from 10-Q 7 pages Separation Agreement

from 10-Q 38 pages I II Agreement of Sublease

from 10-Q 1 page Enzon Pharmaceticals, Inc Amended and Restated 2013 Outside Director Compensation Plan